Tạp chí Tim mạch học Việt Nam

Article detail

Article detail description

Home
NGHIÊN CỨU LÂM SÀNG Issue: Số 118

Association Between Heart Rate Control at Discharge and 6-Month Cardiovascular Readmission in Patients With Chronic Heart Failure at Viet Tiep Friendship Hospital

Published: November 28, 2025
Views: 74

Abstract

Objective: To evaluate the association between discharge heart rate and 6-month cardiovascular readmission in patients with chronic heart failure. Methods: A prospective descriptive study was conducted on 105 patients with chronic heart failure admitted to the Cardiology Department of Viet Tiep Friendship Hospital from January 2024 to May 2025. Heart failure was diagnosed according to the 2021 ESC criteria. Patients were categorized into two groups based on discharge heart rate: <70 bpm (n=42) and ≥70 bpm (n=63). Clinical characteristics, comorbidities, echocardiographic indices, and laboratory findings were collected. Cardiovascular readmissions (heart failure exacerbation, myocardial infarction, arrhythmias) were recorded at 1, 3, and 6 months. Survival analysis was performed using the Kaplan–Meier method, and relative risk estimates were obtained using Cox proportional hazards models. Results: The mean age was 68.81 ± 12.1 years, and 50.48% were women. Common comorbidities included hypertension (60.95%), atrial fibrillation (29.52%), valvular heart disease (27.62%), and chronic kidney disease (21.9%). Dyspnea on exertion (95.24%), chest pain (79.05%), pulmonary rales (67.62%), and lower-limb edema (57.14%) were the most frequent symptoms. Mean left ventricular ejection fraction (LVEF) was 40.9 ± 15.9%. During the first month, cardiovascular readmission was significantly higher in the ≥70 bpm group (22.22% vs. 2.38%; p<0.05). At 3 months, no significant difference was observed (22.22% vs. 23.81%; p>0.05). At 6 months, readmission remained higher in the ≥70 bpm group (23.81% vs. 7.14%; p<0.05). Kaplan–Meier analysis showed an increased risk of cardiovascular readmission in the ≥70 bpm group (HR=1.6; 95% CI: 0.85–3.04), although this did not reach statistical significance. Conclusion: Discharge heart rate ≥70 bpm was associated with a higher risk of cardiovascular readmission, at 1 and 6 months post-discharge, highlighting the prognostic importance of adequate heart rate control in chronic heart failure.

References

1.
Swedberg K, Komajda M, Böhm M, et al. Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study. J Am Coll Cardiol. 2012;59(22):1938-1945. doi:10.1016/j.jacc.2012.01.020
2.
Fox K, Ford I, Steg PG, Tendera M, Ferrari R; BEAUTIFUL Investigators. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9641):807-816. doi:10.1016/S0140-6736(08)61170-8
3.
McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-3726. doi:10.1093/eurheartj/ehab368
4.
Nguyen TT, et al. Symptom burden among elderly patients with heart failure hospitalized in Hanoi. Int J Environ Res Public Health. 2022;19(20).
5.
Nguyen DK, et al. Clinical and subclinical characteristics of patients with acute heart failure admitted to Cho Ray Hospital. Vietnam Medical Journal. 2024;542(1):7-10.
6.
Böhm M, Komajda M, Borer JS, et al. Duration of chronic heart failure affects outcomes with preserved effects of heart rate reduction with ivabradine: findings from SHIFT. Eur J Heart Fail. 2018;20(2):373-381. doi:10.1002/ejhf.1021
7.
Lam DT, Tran VA. Results of heart rate control with ivabradine in patients with chronic heart failure. Can Tho Journal of Medicine and Pharmacy. 2019;17:5-11.

Files

Article Views74
Document Views4
Downloads0
Section NGHIÊN CỨU LÂM SÀNG
Issue Số 118
Pages 144-150